Multifunctional Therapeutic Potential of Corynoline: A Benzophenanthridine derived Alkaloid

Corynoline is a naturally occurring benzophenanthridine-derived alkaloid widely isolated from plants of the genus Corydalis, which have been used for centuries in traditional herbal medicine for the management of inflammation, pain, and infectious diseases. Belonging to the structurally unique benzophenanthridine class, corynoline possesses a distinctive chemical scaffold that underlies its diverse and potent biological interactions. In recent years, a growing body of experimental studies has demonstrated that corynoline exhibits a remarkably wide range of pharmacological activities, including anti-inflammatory, anticancer, neuroprotective, hepatoprotective, cardioprotective, anti-osteoporotic, and renal ischemia-reperfusion protective effects. These multifaceted activities are mediated through the modulation of several cellular signaling pathways, including Nrf2/HO-1, MAPKs, NF-κB, NOS3, AKT/GSK3β/Nrf2, STAT3/Bcl-2, and Src/JNK, highlighting its capacity to simultaneously target multiple disease-relevant molecular networks. This review aims to comprehensively summarize current knowledge regarding the chemical characteristics, pharmacological activities, underlying molecular mechanisms, and therapeutic prospects of corynoline. Despite its promising pharmacological profile, the clinical translation of corynoline remains hindered by insufficient pharmacokinetic data, limited bioavailability studies, and inadequate toxicity evaluations. Therefore, further rigorous preclinical and clinical investigations are warranted to fully elucidate its safety profile, therapeutic efficacy, and drug-like properties. By integrating mechanistic insights with translational perspectives, this article seeks to stimulate future research aimed at harnessing corynoline's unique chemical scaffold for the development of innovative and effective therapeutic strategies across multiple disease domains.